SNAQ, the pioneering diabetes management platform, is thrilled to announce the launch of its latest breakthrough: AI-powered meal glucose prediction. This revolutionary feature allows individuals using continuous glucose monitors (CGMs) to receive personalized predictions of their glucose response for any meal—before they even take a bite. Early user feedback has been overwhelmingly positive, reinforcing the game-changing nature of this innovation.

Harnessing the power of a proprietary deep learning model, SNAQ’s meal glucose predictions leverage a digital twin approach—an industry-first in diabetes. Built upon one of the most comprehensive datasets combining dietary intake, glucose levels, insulin usage, and physical activity, this advancement provides users with actionable insights to optimize their food choices and improve glucose management like never before.

“Our meal glucose prediction feature represents a monumental leap in diabetes care,” said Nico Previtali, CTO of SNAQ. “This is not just another CGM app feature; it’s an unprecedented application of AI and deep learning in personal health. By analyzing extensive real-world data, our technology provides highly individualized glucose forecasts, empowering users with insights that were previously impossible.”

Adding to this milestone, SNAQ is also proud to announce the successful closing of its latest financing round, led by the Diabetes Venture Fund at Serpentine Ventures. This round ensures the company’s path to breakeven despite a challenging fundraising environment, underscoring investor confidence in SNAQ’s vision and cutting-edge technology.

“We continue to be excited by the transformative potential of the SNAQ platform, and its positioning as the first solution to successfully address very real and pressing unmet needs," said Craig Cooper, Partner at Serpentine Ventures. "The technology is backed by strong data, the team continues to execute flawlessly, and this latest breakthrough is further evidence of their tremendous progress.”

“This funding is a testament to the impact SNAQ is having in the diabetes space,” said Aurelian Briner, CEO of SNAQ. “We’ve secured the resources to scale our innovations and continue transforming diabetes management for millions worldwide.”

Looking ahead, SNAQ is gearing up to introduce more groundbreaking diabetes innovations, leveraging its proprietary data and the latest advancements in AI. With its commitment to managing the impact of food on health, SNAQ remains at the forefront of empowering people with diabetes to make more informed decisions about their nutrition and health.

For more information, visit www.snaq.ai or contact [email protected].